[go: up one dir, main page]

WO2005034954A3 - Pharmaceutical compositions of paroxetine containing microcrystalline cellulose, prepared by wet granulation - Google Patents

Pharmaceutical compositions of paroxetine containing microcrystalline cellulose, prepared by wet granulation Download PDF

Info

Publication number
WO2005034954A3
WO2005034954A3 PCT/IB2004/003295 IB2004003295W WO2005034954A3 WO 2005034954 A3 WO2005034954 A3 WO 2005034954A3 IB 2004003295 W IB2004003295 W IB 2004003295W WO 2005034954 A3 WO2005034954 A3 WO 2005034954A3
Authority
WO
WIPO (PCT)
Prior art keywords
prepared
microcrystalline cellulose
pharmaceutical compositions
wet granulation
paroxetine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/IB2004/003295
Other languages
French (fr)
Other versions
WO2005034954A2 (en
Inventor
Pratik Kumar
Girish Kumar Jain
Ashok Kumar Rampal
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ranbaxy Laboratories Ltd
Original Assignee
Ranbaxy Laboratories Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ranbaxy Laboratories Ltd filed Critical Ranbaxy Laboratories Ltd
Priority to EP04769597A priority Critical patent/EP1675574A2/en
Publication of WO2005034954A2 publication Critical patent/WO2005034954A2/en
Publication of WO2005034954A3 publication Critical patent/WO2005034954A3/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2886—Dragees; Coated pills or tablets, e.g. with film or compression coating having two or more different drug-free coatings; Tablets of the type inert core-drug layer-inactive layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The present invention relates to stable pharmaceutical compositions of paroxetine and process for preparation thereof. The pharmaceutical composition includes paroxetine, microcrystalline cellulose, and one or more additional pharmaceutically acceptable inert excipients. The pharmaceutical composition is prepared by a wet granulation technique.
PCT/IB2004/003295 2003-10-08 2004-10-08 Pharmaceutical compositions of paroxetine containing microcrystalline cellulose, prepared by wet granulation Ceased WO2005034954A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
EP04769597A EP1675574A2 (en) 2003-10-08 2004-10-08 Pharmaceutical compositions of paroxetine containing microcrystalline cellulose, prepared by wet granulation

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN1247DE2003 2003-10-08
IN1247/DEL/2003 2003-10-08

Publications (2)

Publication Number Publication Date
WO2005034954A2 WO2005034954A2 (en) 2005-04-21
WO2005034954A3 true WO2005034954A3 (en) 2005-06-02

Family

ID=34430679

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IB2004/003295 Ceased WO2005034954A2 (en) 2003-10-08 2004-10-08 Pharmaceutical compositions of paroxetine containing microcrystalline cellulose, prepared by wet granulation

Country Status (2)

Country Link
EP (1) EP1675574A2 (en)
WO (1) WO2005034954A2 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007012968A2 (en) * 2005-07-29 2007-02-01 Aurobindo Pharma Ltd Stable dosage form of an antidepressant
EP1926479A4 (en) * 2005-08-26 2013-01-09 Bpsi Holdings Inc Drug compositions containing controlled release hypromellose matrices
WO2007132344A2 (en) * 2006-05-09 2007-11-22 Aurobindo Pharma Limited Controlled release compositions of an antidepressant agent
CN102525966B (en) * 2010-12-13 2016-06-29 江苏万全特创医药生物技术有限公司 A kind of tablet containing paroxetine and preparation method thereof

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002055062A2 (en) * 2001-01-11 2002-07-18 Synthon B.V. Pharmaceutical tablet comprising paroxetine mesylate
WO2002069969A1 (en) * 2001-03-02 2002-09-12 A/S Gea Farmaceutisk Fabrik A process for the manufacture of pharmaceutical tablets containing paroxetine hydrochloride anhydrate
WO2003057151A2 (en) * 2001-12-28 2003-07-17 Teva Pharmaceutical Industries Ltd. A stable pharmaceutical formulation of paroxetine hydrochloride anhydrous and a process for preparation thereof
WO2004058229A1 (en) * 2002-12-24 2004-07-15 Biovail Laboratories Inc. Modified release formulations of selective serotonin re-uptake inhibitors

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002055062A2 (en) * 2001-01-11 2002-07-18 Synthon B.V. Pharmaceutical tablet comprising paroxetine mesylate
WO2002069969A1 (en) * 2001-03-02 2002-09-12 A/S Gea Farmaceutisk Fabrik A process for the manufacture of pharmaceutical tablets containing paroxetine hydrochloride anhydrate
WO2003057151A2 (en) * 2001-12-28 2003-07-17 Teva Pharmaceutical Industries Ltd. A stable pharmaceutical formulation of paroxetine hydrochloride anhydrous and a process for preparation thereof
WO2003057150A2 (en) * 2001-12-28 2003-07-17 Teva Pharmaceutical Industries Ltd. A stable pharmaceutical formulation of paroxetine hydrochloride and a process for preparation thereof
WO2004058229A1 (en) * 2002-12-24 2004-07-15 Biovail Laboratories Inc. Modified release formulations of selective serotonin re-uptake inhibitors

Also Published As

Publication number Publication date
EP1675574A2 (en) 2006-07-05
WO2005034954A2 (en) 2005-04-21

Similar Documents

Publication Publication Date Title
WO2004062577A3 (en) Two or more enteric materials to regulate drug release
AU2003270255A1 (en) Fast releasing, solid administration form for oral application of active ingredients which are hard to dissolve
WO2001032632A3 (en) Pharmaceutically active 4-substituted pyrimidine derivatives
AU2003244632A1 (en) Bicyclo-pyrazoles active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them
AU2003227741A1 (en) Aminoindazole derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them
AU2003244649A1 (en) Bicyclo-pyrazoles active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them
WO2006024486A3 (en) Amide derivatives of 3-phenyl dihydropyrimido[4,5-d]pyrimidinones, their manufacture and use as pharmaceutical agents
PL343771A1 (en) N-substituted aminotetralins as ligands for the neuropeptide y y5 receptor useful in the treatment of obesity and other disorders
WO2007090882A3 (en) Pharmaceutical extended release compositions comprising pramipexole
WO2001095856A3 (en) Urea derivative useful as an anti-cancer agent and process for preparing same
WO2003057150A3 (en) A stable pharmaceutical formulation of paroxetine hydrochloride and a process for preparation thereof
NO20050018L (en) Lasofoxifene tablets and coatings
PL367447A1 (en) Novel 2h-pyridazine-3-one derivatives, pharmaceutical compositions containing the same and a process for the preparation of the active ingredient
NO20043367L (en) Oral pharmaceutical preparation
WO2005089718A3 (en) Pharmaceutical compositions
WO2004093800A3 (en) Thyronamine derivatives and analogs and methods of use thereof
WO2003014079A8 (en) Stable polymorph of flibanserin, technical process for its preparation and the use thereof for preparing medicaments
WO2003086362A3 (en) Method of stabilizing bupropion hydrochloride tablets
CA2419314A1 (en) Preparation of risperidone
WO2006138735A3 (en) Gel compositions for topical administration
AU2002358676A1 (en) Hydroxyphenyl-pyrazole derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them
WO2003026610A3 (en) Process for the preparation of fast dissolving dosage form
DE60112956T2 (en) CRYSTALLINE FORMS OF FLUVASTATIN SODIUM
WO2006042954A8 (en) 2-amido-4-phenylthiazole derivatives, the preparation and the therapeutic use thereof
FR2819720B1 (en) NEW FENOFIBRATE TABLETS

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): BW GH GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 2004769597

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 2448/DELNP/2006

Country of ref document: IN

WWP Wipo information: published in national office

Ref document number: 2004769597

Country of ref document: EP

WWW Wipo information: withdrawn in national office

Ref document number: 2004769597

Country of ref document: EP